Through an in silico analysis of MyoD ChIP-seq datasets, we were surprised to discover that aside from established binding of MyoD on differentiation genes, such as MyHC and TnnT,63 whose expression in RMS tumor cells we had shown to be dependent on MyoD, enrichment peaks were also significantly displayed on stemness genes. The gene discussed is MYOD1; the disease is neoplasm.